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Abstract
Objective—To determine outcomes, after use of propensity score (PS) techniques to create
balanced groups, according to whether a woman undergoes elective repeat cesarean (ERCD) or
trial of labor (TOL).
Study Design—Women eligible for a TOL with 1 previous low transverse incision were
categorized according to whether they underwent an ERCD or TOL. A PS technique was used to
develop ERCD and TOL groups with comparable baseline characteristics. Outcomes were
assessed using conditional logistic regression.
Results—Rates of endometritis, operative injury, respiratory distress syndrome and newborn
infection were lower, while rates of hysterectomy and wound complication were higher, in the
ERCD group.
Conclusion—PS techniques can be used to generate comparable ERCD and TOL groups. Some
types of maternal morbidity, such as hysterectomy are higher, while others, such as operative
injury, are lower in the ERCD group. Although the absolute risk is low, neonatal morbidity
appears to be lower in the ERCD group.
Keywords
elective repeat cesarean; propensity score; trial of labor
Introduction
In March 2010 the Agency for Healthcare Research and Quality (AHRQ) published the
results of an evidence report and technology assessment concerning women undergoing
either a trial of labor (TOL) after previous cesarean or an elective repeat cesarean delivery
(ERCD).1 The evidence report was based almost entirely on observational studies, and the
lack of randomized trials to compare these two approaches to delivery was cited as a critical
research gap. It also was noted that “several papers indicate that such a trial is unlikely in the
United States”, due both to the perception that pregnant women would not be willing to be
randomized to a particular delivery approach and to the large sample size that would be
required to power such a study adequately.
A randomized trial is considered the gold standard of clinical research given that, among
other reasons, it is a design that optimizes the balance of observed as well as unobserved
baseline covariates. Observational studies, conversely, are more prone to selection bias,
often resulting in unbalanced baseline group differences. Various methods such as
stratification, matching, and regression have been used to minimize this potential bias,
however, these methods have limitations with regard to the number of covariates that can be
incorporated.2 This limitation to control for confounding factors was specifically mentioned
in the AHRQ Vaginal Birth After Cesarean evidence report.3
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One statistical method introduced by Rosenbaum and Rubin, the propensity score,
potentially circumvents these covariate restrictions.4 The propensity score is a single
variable that represents the collection of baseline covariates for each individual or patient
and is defined as the probability of being treated conditional on the individual's covariate
values. This score, therefore, can be used to develop groups that differ according to the
exposure of interest, but have otherwise similar baseline characteristics, and its use creates
“the observational study analog of randomization in experiments”.5 Although several
methods have been proposed to optimize inter-group similarity, Rosenbaum and Rubin
found the nearest Mahalanobis metric matching within calipers defined by the propensity
score to produce the best balance of baseline covariates between groups.6 Further discussion
on propensity score methodology can be found in several papers and in
textbooks.7, 8, 9, 10, 11
Given the past and projected absence of randomized trials comparing ERCD to TOL,
propensity scores offer an alternate method to compare the outcomes related to the approach
to delivery after a prior cesarean. This relatively new statistical technique has rarely been
used in obstetrics and gynecology and does not appear to have been utilized in the context of
TOL.12, 13 Correspondingly, this analysis was designed to assess, using propensity score
techniques, the maternal and neonatal outcomes associated with an ERCD compared with a
TOL.
Materials and Methods
From 1999 through 2002, data were collected in a registry (the Cesarean Registry) by the
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Maternal-Fetal Medicine Units Network. This observational study, which included data on
all women with a prior cesarean who underwent delivery, was conducted at 19 clinical
centers throughout the United States and was approved by the institutional review board of
each participating center. Study personnel at the participating medical centers abstracted
data from patient charts under a waiver of informed consent. Further detail on the Cesarean
Registry can be obtained from previously published articles.14, 15
This secondary analysis of the Cesarean Registry included women with a live, singleton,
term, vertex gestation and one prior low transverse incision (LTCS) who had an ERCD or a
TOL whose labor began spontaneously. Term was defined as greater than 36 weeks and 6
days gestation. An ERCD was defined as a cesarean delivery without any indication other
than the prior cesarean. This group included women whose cesarean was scheduled, as well
as those who chose cesarean, in the absence of any other indication, after presenting in labor
or with rupture of membranes. Correspondingly, women who had a repeat cesarean for
indications such as placenta previa or active herpes were excluded. Also, women were
ineligible for the cohort if they had an ERCD prior to 39 weeks without spontaneous labor
or premature rupture of membranes. Women with ERCD and spontaneous labor or rupture
of membranes prior to 39 weeks were included since they were eligible for, and would need
to choose between, the two approaches to delivery. Women with induced labor also were
excluded since this intervention has been associated with a lower probability of success and
a higher probability of uterine rupture, and is not purely a probabilistic possibility but a
choice that a woman and her provider can make.16 A woman who is considering undergoing
a spontaneous TOL or proceeding with an ERCD can only be counseled about the two
approaches, either before or at the time of her labor, if the outcomes related to each
alternative alone are known. This would be true, as well, if she were faced with the choice of
undergoing a labor induction or an ERCD (in which case outcomes of induction versus
ERCD would be studied). The suitability of analyzing women who are induced separately
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from those in spontaneous labor, in the appropriate circumstance, has been recognized in the
literature.17, 18, 19
Propensity scores were used to control for potential covariate imbalances and create
maximally non-biased groups. The propensity scores were generated using logistic
regression and represent the probability of being delivered by an ERCD given baseline
covariate values. Propensity scores were based on the ERCD group to ensure as many
matches could be made as possible since the number of patients in this group was less than
that in the TOL group. All covariates known at 37 weeks of gestation that existed prior to
labor were included (n=43) in the logistic regression without a stepwise procedure. This
included 18 dichotomous variables that were used to represent the different centers from
which patients were enrolled. One-to-one matching without replacement was conducted
using the nearest Mahalanobis distance within calipers defined by the logit of the propensity
score. The Mahalanobis distance was calculated by identifying, a priori, three variables that
highly influenced the probability of cesarean delivery: maternal age, no prior vaginal
delivery and recurrent cesarean indication (i.e., cephalopelvic disproportion (CPD) or failure
to progress (FTP) as the indication for the prior cesarean). This matching method randomly
ordered the treated subjects and chose the first subject in the list. All patients undergoing
TOL who were within 0.25 standard deviation of the logit of the propensity score (or the
caliper) of the identified subject in the ERCD group were selected. The pair with the
smallest Mahalanobis distance was then removed and saved for use in analysis. The process
was repeated until as many matches as possible could be made for the women in the ERCD
group.
The two-sample Kolmogorov-Smirnov test was used to determine if the distributions of the
propensity scores were similar between the two groups.20 The standardized difference was
used to assess the balance of the covariates since it is a property of the sample, and unlike
significance testing, does not depend upon the size of the sample.21 A standardized
difference greater than the absolute value of 10 was used to indicate that the samples were
meaningfully different.22 For the matched cohort, outcomes were compared using
McNemar's test, and odds ratios (OR) and 95% confidence intervals (CIs) were generated
using conditional logistic regression.23 The CIs for number needed to treat were calculated
using the Wilson score method.24
The evaluated maternal outcomes through delivery were: endometritis (clinical diagnosis of
puerperal uterine infection in the absence of findings suggesting another source), wound
complication (seroma, hematoma or infection), uterine rupture (disruption or tear of the
uterine muscle and visceral peritoneum or a uterine muscle separation with extension to
adjacent structures), operative injury (broad ligament hematoma, cystotomy, or bowel or
ureteral injury), peripartum hysterectomy, thromboembolism (deep vein thrombosis or
pulmonary embolus) and maternal death. Evaluated neonatal outcomes collected up to 120
days after delivery or at the time of hospital discharge were: transient tachypnea of the
newborn (TTN), respiratory distress syndrome (RDS), infection including suspected or
confirmed sepsis, acidemia (arterial cord pH less than 7.0), hypoxic ischemic
encephalopathy (HIE), and neonatal death. Cases of uterine rupture, HIE and maternal death
were confirmed by central review. For mothers and neonates, a separate composite adverse
outcome variable representing one or more of these outcomes also was generated. An
additional composite outcome that included only major maternal morbidities was developed
and was defined as the occurrence of hysterectomy, uterine rupture or operative injury.
Statistical analysis was conducted with SAS (SAS Institute, Cary, NC) and, for the matched
analysis, with the use of the R and the R MatchIt library (http://www.r-project.org/). A two-
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tailed nominal p<.05 was considered significant. No adjustments were made for multiple
comparisons.25
Results
Within the Cesarean Registry, 22,068 women with a live, singleton, vertex birth with one
previous LTCS who delivered at term after undergoing a TOL or ERCD were available for
analysis (Figure 1). Seven-hundred fifty-nine women who had indications for cesarean that
would normally preclude a TOL, such as non-reassuring antepartum testing,
malpresentation, placenta previa, myomectomy and active genital herpes were excluded.
Similarly, in order to ensure that women who underwent repeat cesarean truly had no
indication for the cesarean other than their choice, those who were reported to have a
cesarean that was elective but who had a reported indication implying this was not the case
(i.e. CPD, FTP, cord prolapse, non-reassuring tracing or abruption) were excluded (n = 262).
An additional 3188 women who had an ERCD prior to 39 weeks of gestation as well as
3235 who underwent labor induction were not included in this analysis. Patients carrying
fetuses with aneuploidy or congenital malformations, including trisomy 18 and 21, clubbed
foot, cleft palate, and neural tube defect (n = 120) were removed as well. These women were
excluded since the perinatal outcome of interest could be biased by their inclusion. This
process left 14,504 women for analysis, of whom 8297 had a TOL and 6207 had an ERCD.
Of the 8297 women who attempted a TOL, 6421 (77.4%) had a successful vaginal birth after
a previous cesarean (VBAC). Of the 6207 who had an ERCD, 4972 (80.1%) delivered at or
after 39 weeks of gestation without labor and 1235 (19.9%) delivered between 37.0 and 38.6
weeks of gestation due to the onset of labor or premature rupture of membranes.
To generate the propensity scores for the probability of having an ERCD, the 25 baseline
patient variables in Table 1 and 18 dichotomous center variables were used. First-level
interactions of maternal age, no prior vaginal delivery and recurring indication for the prior
cesarean were assessed with all of the variables. Twenty-two interactions were significant at
the p<0.05 level and were included in the final propensity score model. This resulted in
12,282 women (84.7% of the original cohort) available for further analysis since those with
missing data for any variable were excluded from the logistic regression. The ERCD group
consisted of 5500 women (44.8%) and the TOL group 6782 (55.2%).
First, we assessed whether the baseline characteristics of the groups, prior to matching, were
similar. Figure 2 plots the distribution of the propensity scores in the two groups. Overall, as
a function of baseline characteristics, the ERCD group had a higher probability of receiving
an ERCD, as indicated by a higher mean propensity score (0.576 ± 0.189 vs. 0.344 ± 0.226,
p<.001). The initial difference in the two groups was further supported by the standardized
difference criterion, which revealed that 17 out of the 43 (39.5%) baseline covariates had a
standardized difference of greater than 10 and were therefore imbalanced by this criterion.
These differences, and the inherent selection bias they represent, supported the need for
further ante hoc adjustment using propensity scores.
Even when two groups differ based on their baseline characteristics and corresponding mean
propensity scores, the possibility that matched groups could be created is indicated when
there is still overlap of the two groups' propensity scores. Figure 2 demonstrates that such a
propensity score overlap between the two groups did exist. Thus, one-to-one Mahalanobis
matching without replacement on the logit of the propensity score using calipers equal to
0.25 standard deviations of the propensity score was conducted to engender better covariate
balance. This matching process resulted in the creation of 3981 matched pairs of ERCD and
TOL patients. Figure 3 displays the distributions of the two matched groups' propensity
scores, which in contrast to the distributions illustrated in Figure 2, reveal a high degree of
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overlap and similarity of shape between the two groups. This improved covariate balance
also was reflected in the difference in the means of the propensity scores, which was
reduced from 0.232 prior to propensity score-based matching to 0.022 post-matching (post-
matching mean propensity scores of 0.512 ± 0.176 in the ERCD group and 0.490 ± 0.168 in
the TOL group, p<.001). The standardized difference criterion analysis further confirmed
the groups' similarity as all baseline covariates were balanced and the highest standardized
difference was only 7.5 (Table 2).
Table 3 presents the major maternal and neonatal outcomes, stratified by approach to
delivery, of the matched cohort. The TOL success rate was 68.1% with 2710 women
experiencing a successful VBAC. The ERCD group was less likely to have endometritis,
operative injury, RDS, or newborn infection. Conversely, the ERCD group was more likely
to have a wound complication or hysterectomy. Differences between the groups were not
found for TTN, acidemia or neonatal death. All 31 (0.8%) cases of uterine rupture occurred
in the TOL group. One case each of thromboembolism and maternal death occurred in the
ERCD group with none in the TOL group. The maternal death was attributed to amniotic
fluid embolism. All three cases (0.1%) of HIE occurred in the TOL group. Overall, the odds
of maternal composite morbidity was 33% lower in the ERCD group (OR 0.67, 95% CI
0.53–0.83), while the odds of major maternal morbidity was 65% lower (OR 0.35, 95% CI
0.20 – 0.62). The neonatal composite adverse outcome also was lower in the ERCD group
by 33% (OR 0.67, 95% CI 0.55–0.80). This analysis implies that 62 women (95% CI 40–
138) must undergo an ERCD to prevent one maternal adverse outcome, while 43 women
(95% CI 29–78) must undergo an ERCD to prevent one neonatal adverse outcome.
Comment
This analysis was undertaken to compare pregnancy outcomes in women with one prior
LTCS undergoing ERCD or TOL after propensity scores were used to lessen potential
selection bias and create two groups with similar observed baseline covariates. Indeed, this
analysis demonstrated that prior to matching, the ERCD and TOL groups were significantly
different with regard to baseline characteristics, but that after matching based on propensity
scores, two groups of similar patients could be created. The highest standardized difference
found after matching was 7.5, a value below the cut-off of 10 that indicates a meaningful
inter-group difference. This analysis also demonstrated that even once confounding bias is
minimized, some types of maternal morbidity, such as hysterectomy are higher, while
others, such as operative injury, are lower in the ERCD group. Also, although the absolute
risk is low, neonatal morbidity appears to be lower in the ERCD group. For the chosen
composite outcomes, ERCD was associated with a lower odds of maternal and neonatal
morbidity.
Several other studies have compared maternal and neonatal outcomes for women with a
prior LTCS according to delivery approach. However, these studies may not have
adequately controlled for patient characteristics. For example, in their investigation,
McMahon et al. reported that an ERCD reduced major maternal complications, (rupture,
hysterectomy or operative injury) by 44%.26 However, the investigators controlled for only
7 baseline variables, leaving the potential for omitted variable bias. Moreover, simulation
techniques by Peduzzi et al. have found that the validity of a logistic regression model may
become problematic when the number of events relative to the number of independent
variables is less than 10.27 The major composite outcome in the McMahon et al. analysis
had 77 events, which was just enough to meet the Peduzzi et al. criterion; however, the
analysis of three individual outcomes of hysterectomy (n=11), uterine rupture (n=11) and
operative injury (n=59) did not meet this criterion.
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Other studies have had even less adjustment for potential confounding factors. In an analysis
of outcomes of 1755 women who underwent either a TOL or an ERCD, there was a
significant difference between the groups for each of the eight baseline characteristics
assessed.28 Yet, of the nine maternal outcomes reported, only 5 were evaluated in a
multivariable analysis. Similarly, in a four-year prospective cohort study, in which maternal
and infant outcomes were assessed according to delivery approach, only 3 baseline
characteristics were compared and no adjustment was performed.29
Limitations of the present study should be noted. The results of this analysis may not apply
to a population with different epidemiologic characteristics. Specifically, the matches were
made by identifying women who underwent a TOL with spontaneous labor and who were
similar to those who underwent an ERCD. This resulted in the final overall matched cohort
being more similar, in terms of their baseline characteristics, to the original ERCD group.
Most of the women in the matched cohort, for example, did not have a previous vaginal
delivery, and this factor has been shown to lead to a higher TOL success rate as well as to a
lower chance of maternal and neonatal morbidity.30 Thus, if there was a woman, or a group
of women, who had a higher chance of achieving a vaginal birth after cesarean than the 68%
of the group used in the matched analysis, the differences in outcomes could be less or even
nonexistent. Also, even with a large observational study such as the Cesarean Registry there
remains limited capacity to assess differences in rare maternal and neonatal outcomes
(death, thromboembolism, hypoxic ischemic encephalopathy). A larger registry, such as that
created on a national-level, may be able to better address these rare outcomes. Lastly, the
composite outcomes, chosen based on prior morbidities that have been evaluated in the
context of TOL studies, include morbidities with a range of clinical implications, and should
be interpreted in conjunction with the individual outcome data.
It is important to note that the results of this analysis are only applicable for the comparison
of the outcomes of spontaneous TOL and ERCD. This is a legitimate comparison to make,
for although some women will require a labor induction, these women can choose at that
point in time whether they wish to undergo a labor induction or ERCD. Although women
cannot “choose” a spontaneous labor, they can choose to undertake TOL in that setting, and
as such require data derived from the specific comparison of spontaneous TOL with ERCD.
Conversely, counseling based on an aggregate population, which includes women who
undergo labor induction, may give inaccurate insights into morbidity and outcomes for
women with spontaneous labor. For example, induction has been shown to be associated
with a higher risk of uterine rupture, postpartum hemorrhage, cesarean delivery and neonatal
ICU admissions.31, 32 That said, because labor induction has been associated with a lower
rate of vaginal delivery and a higher rate of uterine rupture, the frequency of adverse
outcome should only be greater among a general population of women undergoing an
induced TOL, if such women were included or analyzed alone in comparison to ERCD.
Lastly, propensity score techniques can balance observed covariates but unlike a randomized
trial, cannot control for unmeasured covariates. Nevertheless, because a randomized trial
comparing ERCD to TOL of sufficient size likely will never be completed, techniques that
ensure comparability between comparison groups are important to use in an effort to
overcome inherent inter-group differences. The propensity score analysis presented here is
such a technique that can be used to balance the groups on their observed covariates and
generate a less biased comparison of outcomes.
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Flow chart illustrating the development of the study groups.
LTCS, low transverse cesarean section; TOL, trial of labor; CD, cesarean delivery, CPD,
cephalopelvic disproportion; FTP, failure to progress; ERCD, elective repeat cesarean
delivery, VBAC, vaginal birth after cesarean
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Distribution of the propensity scores, prior to matching, stratified by approach to delivery.
TOL, trial of labor; ERCD, elective repeat cesarean delivery
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Distribution of the propensity scores, after matching, stratified by approach to delivery.
TOL, trial of labor; ERCD, elective repeat cesarean delivery
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Table 1
Baseline characteristics of the unmatched cohort, stratified by approach to delivery
Characteristic ERCD N = 5500 TOL N = 6782 SDiff
Demographics
 Caucasian 2703 (49.1) 2500 (36.9) 25.0
 Married 3597 (65.4) 3844 (56.7) 18.0
 Prenatal care 5466 (99.4) 6667 (98.3) 10.1
 Private medical payment at delivery 3018 (54.9) 2962 (43.7) 22.5
 Body mass index at delivery 32.4 (28.7, 37.4) 30.6 (27.2, 34.8) 31.2
 Maternal age 29 (25, 33) 28 (24, 32) 15.0
Past obstetric history
 Prior cesarean indication of CPD/FTP/failed forceps or vacuum 3031 (55.1) 2474 (36.5) 38.1
 < 2 years since prior cesarean delivery 577 (10.5) 566 (8.3) 7.3
 No prior vaginal delivery 4682 (85.1) 3681 (54.3) 71.3
 No prior VBAC 5235 (95.2) 4584 (67.6) 75.8
Current pregnancy history
 EDC confirmation by first trimester US 1814 (33.0) 1615 (23.8) 20.4
 Diabetes 437 (7.9) 240 (3.5) 19.0
 Asthma 380 (6.9) 493 (7.3) −1.4
 Thyroid disease 173 (3.1) 148 (2.2) 6.0
 Seizure disorder 38 (0.7) 43 (0.6) 0.7
 Chronic hypertension 70 (1.3) 40 (0.6) 7.1
 Heart disease 63 (1.1) 68 (1.0) 1.4
 Cigarette use 675 (12.3) 954 (14.1) −5.3
 Alcohol use 153 (2.8) 228 (3.4) −3.4
 Street drug use 108 (2.0) 263 (3.9) −11.4
 Preterm labor requiring tocolysis 60 (1.1) 124 (1.8) −6.2
 Infection 1502 (27.3) 2154 (31.8) −9.8
 Antepartum antibiotic administration 1233 (22.4) 1677 (24.7) −5.4
 Gestational hypertension/preeclampsia 208 (3.8) 178 (2.6) 6.6
 Other maternal co-morbidity
a 85 (1.5) 160 (2.4) −5.9
ERCD, elective repeat cesarean; TOL, trial of labor; SDiff, the standardized difference; CPD cephalopelvic disproportion; FTP, failure to progress;
VBAC, vaginal birth after a prior cesarean; EDC, estimated date of confinement; US, ultrasound
Data presented as n (%) or median (interquartile range)
a
Other maternal co-morbidity includes, prior to admission, abruption, pulmonary edema, any steroid use, renal disease or connective tissue
disorder.
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Table 2
Baseline characteristics of the matched cohort, stratified by approach to delivery.
Characteristic ERCD N = 3981 TOL N = 3981 SDiff
Demographics
 Caucasian 1700 (42.7) 1656 (41.6) 2.2
 Married 2485 (62.4) 2474 (62.1) 0.6
 Prenatal care 3951 (99.2) 3944 (99.1) 1.9
 Private medical payment at delivery 1979 (49.7) 1939 (48.7) 2.0
 Body mass index at delivery 31.4 (28.2, 35.8) 31.1 (27.5, 35.2) 6.0
 Maternal age 29 (24, 33) 28 (24, 33) 2.0
Past obstetric history
 Prior cesarean indication of CPD/FTP/failed forceps or vacuum 1887 (47.4) 1738 (43.7) 7.5
 < 2 years since last cesarean delivery 436 (11.0) 422 (10.6) 1.1
 No prior vaginal delivery 3241 (81.4) 3209 (80.6) 2.0
 No prior VBAC 3717 (93.4) 3711 (93.2) 0.6
Current pregnancy history
 EDC confirmation by first trimester US 1133 (28.5) 1094 (27.5) 2.2
 Diabetes 202 (5.1) 184 (4.6) 2.1
 Asthma 266 (6.7) 257 (6.5) 0.9
 Thyroid disease 102 (2.6) 101 (2.5) 0.2
 Seizure disorder 29 (0.7) 23 (0.6) 1.9
 Chronic hypertension 30 (0.8) 28 (0.7) 0.6
 Heart disease 41 (1.0) 42 (1.1) −0.2
 Cigarette use 448 (11.3) 433 (10.9) 1.2
 Alcohol use 110 (2.8) 107 (2.7) 0.5
 Street drug use 89 (2.2) 81 (2.0) 1.4
 Preterm labor requiring tocolysis 53 (1.3) 48 (1.2) 1.1
 Infection 1148 (28.8) 1177 (29.6) −1.6
 Antepartum antibiotic administration 920 (23.1) 935 (23.5) −0.9
 Gestational hypertension/preeclampsia 141 (3.5) 128 (3.2) 1.8
 Other maternal co-morbidity
a 69 (1.7) 72 (1.8) −0.6
ERCD, elective repeat cesarean; TOL, trial of labor; SDiff, standardized difference; CPD, cephalopelvic disproportion; FTP, failure to progress;
VBAC, vaginal birth after a prior cesarean; EDC, estimated date of confinement; US, ultrasound
Data represent n (%) or median (1st, 3rd quartile)
a
Other maternal morbidity includes prior to admission, abruption, pulmonary edema, any steroid use, renal disease or connective tissue disorder.
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Table 3
Maternal and neonatal outcomes of the matched cohort, stratified by approach to delivery.
Outcome ERCD N = 3981 N (%) TOL N = 3981 N (%) P-value
a Conditional OR (95% CI)
Maternal
 Endometritis 85 (2.1) 144 (3.6) <.001 0.57 (0.43 – 0.75)
 Wound complication 34 (0.9) 17 (0.4) 0.02 2.00 (1.12 – 3.58)
 Operative injury 6 (0.2) 20 (0.5) 0.006 0.30 (0.12 – 0.75)
 Hysterectomy 12 (0.3) 3 (0.1) 0.02 4.00 (1.13 – 14.17)
 Maternal composite
b 136 (3.4) 200 (5.0) <.001 0.67 (0.53 – 0.83)
Neonatal
 TTN 119 (3.0) 107 (2.7) 0.41 1.12 (0.86 – 1.46)
 RDS 41 (1.0) 68 (1.7) 0.01 0.60 (0.41 – 0.89)
 Infection 124 (3.1) 211 (5.3) <.001 0.58 (0.46 – 0.72)
 Acidemia 14 (0.4) 25 (0.6) 0.08 0.56 (0.29 – 1.08)
 Neonatal death 1 (0.03) 2 (0.05) 0.56 0.50 (0.05 – 5.51)
 Neonatal composite
c 202 (5.1) 295 (7.4) <.001 0.67 (0.55 – 0.80)
ERCD, elective repeat cesarean; TOL, trial of labor; OR, odds ratio; CI, confidence interval; TTN, transient tachypnea of the newborn; RDS,
respiratory distress
a
P-value from McNemar's test
b
Maternal composite outcome includes uterine rupture, endometritis, wound complication, operative injury, hysterectomy, thromboembolism or
maternal death.
c
Neonatal composite outcome includes TTN, RDS, infection, acidemia, neonatal death or hypoxic ischemic encephalopathy.
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